These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 24854414)

  • 1. The other randomization - methods for labeling drug kits.
    Coleman DA; Yu R
    Contemp Clin Trials; 2014 Jul; 38(2):270-4. PubMed ID: 24854414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blinding properties of methods for supplying drug kits to investigational sites.
    Yu R; Coleman DA
    Contemp Clin Trials Commun; 2015 Oct; 1():22-27. PubMed ID: 29736435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some practical problems in implementing randomization.
    Downs M; Tucker K; Christ-Schmidt H; Wittes J
    Clin Trials; 2010 Jun; 7(3):235-45. PubMed ID: 20484491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blinding strategies in the conduct and reporting of a randomized placebo-controlled device trial.
    Houweling AH; Shapiro S; Cohen JM; Kahn SR
    Clin Trials; 2014 Oct; 11(5):547-52. PubMed ID: 24902921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized double-blinded placebo-controlled trial on the effect of dehydroepiandrosterone for 16 weeks on ovarian response markers in women with primary ovarian insufficiency.
    Yeung TW; Li RH; Lee VC; Ho PC; Ng EH
    J Clin Endocrinol Metab; 2013 Jan; 98(1):380-8. PubMed ID: 23144466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are we really that blind?
    van der Meulen EA
    J Biopharm Stat; 2005; 15(3):479-89. PubMed ID: 15920892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial.
    Schwartz S; Etropolski M; Shapiro DY; Okamoto A; Lange R; Haeussler J; Rauschkolb C
    Curr Med Res Opin; 2011 Jan; 27(1):151-62. PubMed ID: 21162697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors.
    Haahr MT; Hróbjartsson A
    Clin Trials; 2006; 3(4):360-5. PubMed ID: 17060210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethical pitfalls in neonatal comparative effectiveness trials.
    Modi N
    Neonatology; 2014; 105(4):350-1. PubMed ID: 24931328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalized method for adaptive randomization in clinical trials.
    Russell D; Hoare ZS; Whitaker R; Whitaker CJ; Russell IT
    Stat Med; 2011 Apr; 30(9):922-34. PubMed ID: 21284014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Random allocation software for parallel group randomized trials.
    Saghaei M
    BMC Med Res Methodol; 2004 Nov; 4():26. PubMed ID: 15535880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized and double-blind studies--demands and reality as demonstrated by two examples of mistletoe research.
    Rostock M; Huber R
    Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():18-22. PubMed ID: 15353898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designing choice experiments with many attributes. An application to setting priorities for orthopaedic waiting lists.
    Witt J; Scott A; Osborne RH
    Health Econ; 2009 Jun; 18(6):681-96. PubMed ID: 18770875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a list of look-alike drug names with recommended tall man letters.
    Otero López MJ; Martín Muñoz R; Sánchez Barba M; Abad Sazatornil R; Andreu Crespo A; Arteta Jiménez M; Bermejo Vicedo T; Cajaraville Ordoñana G;
    Farm Hosp; 2011; 35(5):225-35. PubMed ID: 21807543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing information on drug exposure by collection of package code information in questionnaire surveys.
    Quinzler R; Schmitt SP; Szecsenyi J; Haefeli WE
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):1024-30. PubMed ID: 17457950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Waiting list randomized controlled trial within a case-finding design: methodological considerations.
    Ronaldson S; Adamson J; Dyson L; Torgerson D
    J Eval Clin Pract; 2014 Oct; 20(5):601-5. PubMed ID: 24943741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revisiting the level of evidence in randomized controlled clinical trials: A simulation approach.
    Bajard A; Chabaud S; Pérol D; Boissel JP; Nony P
    Contemp Clin Trials; 2009 Sep; 30(5):400-10. PubMed ID: 19576298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug supply by ration kits: report of an evaluation.
    Essent Drugs Monit; 1991; (11):12-4. PubMed ID: 12284332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.